INTRODUCTION: Research identifying nicotine dependence (ND) symptoms most appropriate for measurement of adolescent ND and invariant across the range of smoking exposure is hampered by limited sample size and variability of smoking behavior within independent studies. Integrative data analysis, the process of pooling and analyzing data from multiple studies, produces larger and more heterogeneous samples with which to evaluate measurement equivalence across the full continuum of smoking quantity and frequency. METHODS: Data from two studies were pooled to obtain a large sample of adolescent and young adult smokers with considerable variability in smoking. We used moderated nonlinear factor analysis, which produces study equivalent ND scores, to simultaneously evaluate whether 14 DSM ND symptoms had equivalent psychometric properties (1) at different levels of smoking frequency and (2) across a continuous range of smoking quantity, after accounting for study differences. RESULTS: Nine of 14 symptoms were equivalent across levels of smoking frequency and quantity in probability of endorsement at different levels of ND and in ability to discriminate between levels of ND severity. A more precise ND factor score accounted for study and smoking related differences in symptom psychometric properties. CONCLUSIONS: DSM-IV symptoms may be used to reliably assess ND in young populations across a wide range of smoking quantity and frequency and within both nationally representative and geographically restricted samples with different study designs. Symptoms shared across studies produced an equivalently scaled ND factor score, demonstrating that integrating data for the purpose of studying ND in young smokers is viable.
INTRODUCTION: Research identifying nicotine dependence (ND) symptoms most appropriate for measurement of adolescent ND and invariant across the range of smoking exposure is hampered by limited sample size and variability of smoking behavior within independent studies. Integrative data analysis, the process of pooling and analyzing data from multiple studies, produces larger and more heterogeneous samples with which to evaluate measurement equivalence across the full continuum of smoking quantity and frequency. METHODS: Data from two studies were pooled to obtain a large sample of adolescent and young adult smokers with considerable variability in smoking. We used moderated nonlinear factor analysis, which produces study equivalent ND scores, to simultaneously evaluate whether 14 DSM ND symptoms had equivalent psychometric properties (1) at different levels of smoking frequency and (2) across a continuous range of smoking quantity, after accounting for study differences. RESULTS: Nine of 14 symptoms were equivalent across levels of smoking frequency and quantity in probability of endorsement at different levels of ND and in ability to discriminate between levels of ND severity. A more precise ND factor score accounted for study and smoking related differences in symptom psychometric properties. CONCLUSIONS: DSM-IV symptoms may be used to reliably assess ND in young populations across a wide range of smoking quantity and frequency and within both nationally representative and geographically restricted samples with different study designs. Symptoms shared across studies produced an equivalently scaled ND factor score, demonstrating that integrating data for the purpose of studying ND in young smokers is viable.
Authors: David T Ip; Joanna E Cohen; Susan J Bondy; Michael O Chaiton; Peter Selby; Robert Schwartz; Paul McDonald; John Garcia; Roberta Ferrence Journal: Addiction Date: 2012-02 Impact factor: 6.526
Authors: Lisa Dierker; Elizabeth Lloyd-Richardson; Marilyn Stolar; Brian Flay; Stephen Tiffany; Linda Collins; Steffani Bailey; Mark Nichter; Mimi Nichter; Richard Clayton Journal: Drug Alcohol Depend Date: 2005-07-11 Impact factor: 4.492
Authors: Joseph R DiFranza; Judith A Savageau; Kenneth Fletcher; Judith K Ockene; Nancy A Rigotti; Ann D McNeill; Mardia Coleman; Constance Wood Journal: Arch Pediatr Adolesc Med Date: 2002-04
Authors: Jennifer O'Loughlin; Joseph DiFranza; Rachel F Tyndale; Garbis Meshefedjian; Elizabeth McMillan-Davey; Paul B S Clarke; James Hanley; Gilles Paradis Journal: Am J Prev Med Date: 2003-10 Impact factor: 5.043
Authors: Philip H Smith; Jennifer S Rose; Carolyn M Mazure; Gary A Giovino; Sherry A McKee Journal: Drug Alcohol Depend Date: 2014-07-14 Impact factor: 4.492
Authors: David R Strong; Karen Messer; Sheri J Hartman; Kevin P Conway; Allison C Hoffman; Nikolas Pharris-Ciurej; Martha White; Victoria R Green; Wilson M Compton; John Pierce Journal: Drug Alcohol Depend Date: 2015-04-27 Impact factor: 4.492
Authors: Benjamin D Schalet; Patrick Janulis; Michele D Kipke; Brian Mustanski; Steven Shoptaw; Richard Moore; Marianna Baum; Soyeon Kim; Suzanne Siminski; Amy Ragsdale; Pamina M Gorbach Journal: AIDS Behav Date: 2020-11